Mexican pharma snaps up doomed Pfizer plant; AZ launches clotbuster Brilinta in India;

@FiercePharma: NYT explores the sorry state of some pharma manufacturing plants--and their contributions to drug shortages. More | Follow @FiercePharma

> Mexico's Neolpharma bought a Pfizer ($PFE) plant in Caguas, Puerto Rico, that was set to close at the end of this year; the company plans to keep its 130 workers and hire another 60 temporarily. Report

> AstraZeneca ($AZN) rolled out its anti-clotting drug Brilinta in India at a price that the government's new-drug committee considered "competitive." Report

> Mylan ($MYL) agreed to buy an Indian drug manufacturing plant owned by SMS Pharmaceuticals, which specializes in making cancer drugs and APIs, for $32.5 million. Report

> Adding Pfizer's Zyvox to standard therapy for patients with drug-resistant tuberculosis appeared to improve response, but with a high rate of side effects, a study found. Report

> India's Lupin won FDA approval for its oral contraceptive Kurvelo, its version of the Teva ($TEVA) drug Nordette. Report

Biotech News

 @FierceBiotech: The ax drops on hundreds at Human Genome Sciences in wake of GSK buyout. More | Follow @FierceBiotech

 @JohnCFierce: FDA is extending review of BG-12 (MS). Drat. Thought we'd have an approval this year. Big drug for Biogen. More | Follow @JohnCFierce

> BioCryst scoops up early-stage hep C drugs in $101M Presidio acquisition. Article

> Aegerion wins lopsided FDA panel vote backing rare cholesterol disease drug. News

> Abbott slammed after deaths scuttle PhIII kidney disease program. Story

> Actelion abstract details 'promising' macitentan data. Item

Medical Device News

 @FierceMedDev: Boston Scientific's Q3 2012 earnings report has very few bright spots, as restructuring continues. More | Follow @FierceMedDev

 @MarkHFierce: Computer viruses are running wild in hospital medical devices, MIT Technology Review reports. More | Follow @MarkHFierce

 @DamianFierce: Stryker is scaling back its profit projections after a disappointing third quarter. More | Follow @DamianFierce

> Trauson Holdings: China's next med device M&A target. Item

> Baxter posts Q3 growth, but device sales slide. Article

> Medtronic launches MRI-safe pacemaker in Japan. News

Vaccines News

> J. Craig Venter explores printable vaccines. Article

> GSK recalls infant vaccine in Australia. Story

> University of Minnesota researchers call for better flu vaccine. More

> Study: HPV vaccine does not increase signs of sexual activity. More

> Special Report: 10 promising therapeutic vaccines 2012. Report

Pharma Manufacturing News

> Ben Venue begins limited manufacturing at Ohio drug plant. News

> Criminal investigators search site linked to meningitis outbreak. Report

> Watson to sell manufacturing tech to seal $5.9B Actavis deal. Story

> FDA warns stem cell outfit Celltex about GMP no-nos. Article

And Finally... A New Jersey appeals court said a drugmaker isn't liable for a teenage boy's overdose on stolen pills. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.